PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Hermann-Rein-Str.3, 37075, Göttingen, Germany.\', \'Department of Psychiatry and Psychotherapy, University Medical Center, Göttingen, Germany.\', \'Department of Nephrology and Rheumatology, University Medical Center, Göttingen, Germany.\', \'Hospital Clinic, Institute of Neuroscience, IDIBAPS, CIBERSAM, Barcelona, Spain.\', \'Johann Friedrich Blumenbach Institute of Zoology & Anthropology, University of Göttingen, Göttingen, Germany.\', \'Department of Neurology, Hannover Medical School, Hannover, Germany.\', \'Psychiatric Centre Copenhagen, University Hospital, Rigshospitalet, Copenhagen, Denmark.\', \'Department of Anaesthesiology, University Medical Center Göttingen, Göttingen, Germany.\', \'Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Hermann-Rein-Str.3, 37075, Göttingen, Germany. ehrenreich@em.mpg.de.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s10020-021-00381-5
?:hasPublicationType
?:journal
  • Molecular medicine (Cambridge, Mass.)
is ?:pmid of
?:pmid
?:pmid
  • 34565332
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Addressing the \'hypoxia paradox\' in severe COVID-19: literature review and report of four cases treated with erythropoietin analogues.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all